Navigation Links
Stem Cell Transplants in Mice Show Promise for Lou Gehrig's Disease
Date:1/9/2013

WEDNESDAY, Jan. 9 (HealthDay News) -- Stem cells may one day hold promise for a new treatment for people with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, new animal research suggests.

A study of mice found that stem cell transplantation extended their lifespan by 20 days and improved their neuromuscular function by 15 percent.

"There have been remarkable strides in stem cell transplantation when it comes to other diseases, such as cancer and heart failure," study author Dr. Stefania Corti, of the University of Milan in Italy, said in a news release from the American Academy of Neurology.

"ALS is a fatal, progressive, degenerative disease that currently has no cure," Corti said. "Stem cell transplants may represent a promising avenue for effective cell-based treatment for ALS and other neurodegenerative diseases."

The mice involved in the study had an animal version of ALS. They were injected with human neural stem cells taken from human induced pluripotent stem cells -- adult cells genetically reprogrammed to resemble embryonic stem cells.

These injected stem cells traveled to the spinal cord of the mice, where they matured and multiplied, improving the rodents' lifespan and neuromuscular function.

"Our study shows promise for testing stem cell transplantation in human clinical trials," Corti concluded.

Results achieved in animal tests, however, do not necessarily apply to humans.

The study's findings, released Jan. 9, are scheduled for presentation in March at the American Academy of Neurology's annual meeting in San Diego. Data and conclusions presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

People with ALS eventually lose their strength and cannot move or breathe. The American baseball player Lou Gehrig died of the disease in 1941.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on Lou Gehrig's disease.

-- Mary Elizabeth Dallas

SOURCE: American Academy of Neurology, news release, Jan. 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Boomers With Hepatitis C Boosting Demand for Liver Transplants
2. Brain cell transplants in early 2013
3. Half-Match Marrow Transplants Help Some With Sickle Cell
4. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
5. HIV Undetectable in 2 Men After Bone Marrow Transplants: Study
6. Noninvasive imaging technique may help kids with heart transplants
7. Protecting the hearts of those waiting for kidney and liver transplants
8. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
9. U.S. Liver Transplants Declining
10. First, Second Kidney Transplants Have Similar Success: Study
11. More changes in health care needed to fulfill promise of health information technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cell Transplants in Mice Show Promise for Lou Gehrig's Disease
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret that aging ... to a host of health issues, including urinary incontinence. However, results published in ... that good overall muscle strength in older women, particularly in the abdominal and ...
(Date:2/27/2017)... ... , ... The threat of nuclear warfare has long plagued this world. In ... underground testing of nuclear weapons. Years later, when her co-workers began dying, Dot started ... Nuclear Testing,” Clayton exposes the critical decisions made by agencies involved in the nuclear ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... POUGHKEEPSIE, N. ... ) has disclosed that despite scientific studies, the Center for Disease Control ( CDC ... Lyme disease . Kenneth B. Liegner, M.D. has compiled into a single volume ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top ... and genders. And the need for advanced services is growing. , Project WE ... care program, in collaboration with their non-profit partners in their fight against cancer and ...
(Date:2/26/2017)... New York, New York (PRWEB) , ... February ... ... of luxury baby products for wholesale distribution in North America, today announced it ... established online sites. The company, which prides itself on crafting quality and unique ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel and TAMPA, Fla. , Feb. ... emerging medical device company focused on developing cerebral ... applauds the members of the FDA,s Circulatory System ... their acknowledgement of the need for cerebral protection ... "The statements shared by this FDA panel ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
Breaking Medicine Technology: